118 related articles for article (PubMed ID: 8736979)
1. Serum copper and ceruloplasmin concentrations in patients with primary breast cancer.
Yenisey C; Fadiloğlu M; Onvural B
Biochem Soc Trans; 1996 May; 24(2):321S. PubMed ID: 8736979
[No Abstract] [Full Text] [Related]
2. Copper and ceruloplasmin levels in serum of women with breast cancer.
Vaidya SM; Kamalakar PL
Indian J Med Sci; 1998 May; 52(5):184-7. PubMed ID: 9808908
[TBL] [Abstract][Full Text] [Related]
3. Serum MCA, CA 125 and CA 19.9 determination in primary breast cancer.
Yenisey C; Güner G
Biochem Soc Trans; 1996 May; 24(2):302S. PubMed ID: 8736960
[No Abstract] [Full Text] [Related]
4. Cancer associated serum antigen (CASA) levels in patients with breast carcinoma and in 3 control groups without breast cancer.
Meisel M; Weise J; Schwesinger G; Straube W
Arch Gynecol Obstet; 1998; 261(3):159-62. PubMed ID: 9651660
[TBL] [Abstract][Full Text] [Related]
5. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer.
Horgan PG; Byrne J; O'Donoghue J; Mooney E; Grimes H; Given HF
Ir J Med Sci; 1997; 166(4):215-6. PubMed ID: 9394068
[TBL] [Abstract][Full Text] [Related]
6. Serum ceruloplasmin, plasma copper concentration and copper to ceruloplasmin ratio in cervical carcinoma.
Arumanayagam M; Wong FW; Rogers M; Swaminathan R
Gynecol Obstet Invest; 1993; 35(3):175-8. PubMed ID: 8505012
[TBL] [Abstract][Full Text] [Related]
7. [Prostate specific antigen in women].
Michał K; Stanisław R
Ginekol Pol; 2010 Sep; 81(9):704-7. PubMed ID: 20973208
[TBL] [Abstract][Full Text] [Related]
8. Ceruloplasmin level in women with breast disease. Preliminary results.
Ozyilkan O; Baltali E; Ozyilkan E; Tekuzman G; Kars A; Firat D
Acta Oncol; 1992; 31(8):843-6. PubMed ID: 1290632
[TBL] [Abstract][Full Text] [Related]
9. [Serum selenium level as a diagnostic parameter in breast cancer].
Krsnjavi H; Beker D
Helv Chir Acta; 1992 May; 59(1):231-4. PubMed ID: 1526833
[TBL] [Abstract][Full Text] [Related]
10. Evidence for increased non-ceruloplasmin copper in early-stage human breast cancer serum.
Dabek JT; Hyvönen-Dabek M; Härkönen M; Adlercreutz H
Nutr Cancer; 1992; 17(2):195-201. PubMed ID: 1584712
[TBL] [Abstract][Full Text] [Related]
11. [Tumor markers in diagnosis of breast cancer].
Bartel U
Z Arztl Fortbild (Jena); 1991 Oct; 85(20):1015-21. PubMed ID: 1776283
[No Abstract] [Full Text] [Related]
12. Serum hyaluronan (hyaluronic acid) in breast cancer patients.
Delpech B; Chevallier B; Reinhardt N; Julien JP; Duval C; Maingonnat C; Bastit P; Asselain B
Int J Cancer; 1990 Sep; 46(3):388-90. PubMed ID: 2394505
[TBL] [Abstract][Full Text] [Related]
13. Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases.
Matsuura N; Narita T; Mitsuoka C; Kimura N; Kannagi R; Imai T; Funahashi H; Takagi H
Jpn J Clin Oncol; 1997 Jun; 27(3):135-9. PubMed ID: 9255266
[TBL] [Abstract][Full Text] [Related]
14. Selenium in serum as a possible parameter for assessment of breast disease.
Krsnjavi H; Beker D
Breast Cancer Res Treat; 1990 Jul; 16(1):57-61. PubMed ID: 2207347
[TBL] [Abstract][Full Text] [Related]
15. The correlation between serum levels of cytokeratin tumor markers does reflect their molecular characterization.
Gion M; Mione R; Barioli P; Sartorello P; Dal Zennaro E; Gasparini C; Marconato R
Int J Biol Markers; 1994; 9(2):121-2. PubMed ID: 7523542
[No Abstract] [Full Text] [Related]
16. Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice.
Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
Clin Chem; 2005 Aug; 51(8):1558-9. PubMed ID: 16040861
[No Abstract] [Full Text] [Related]
17. Early breast cancer, diet, and plasma copper fractions.
Dabek JT; Hyvönen-Dabek M; Kupila-Rantala T; Hãrkönen M; Adlercreutz H
Ann Clin Lab Sci; 1996; 26(3):215-26. PubMed ID: 8726214
[TBL] [Abstract][Full Text] [Related]
18. Serum ceruloplasmin as a diagnostic marker of cancer.
Senra Varela A; Lopez Saez JJ; Quintela Senra D
Cancer Lett; 1997 Dec; 121(2):139-45. PubMed ID: 9570351
[TBL] [Abstract][Full Text] [Related]
19. Fine-needle aspiration biopsies of breast masses. An additional experience with 1153 cases (1985 to 1988) and a meta-analysis.
Vetrani A; Fulciniti F; Di Benedetto G; Zeppa P; Troncone G; Boscaino A; de Rosa G; Palombini L
Cancer; 1992 Feb; 69(3):736-40. PubMed ID: 1530911
[TBL] [Abstract][Full Text] [Related]
20. [Clinical value of CEA studies in patients with benign and malignant breast diseases with special reference to oncologic after care].
Kunze M; Voss P; Büttner HH; Stranz G; Strache RR
Zentralbl Gynakol; 1987; 109(24):1517-26. PubMed ID: 3442160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
